...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >COMPARISON OF THE EFFICACY AND SAFETY OF TRAMADOL VERSUS TAPENTADOL IN ACUTE OSTEOARTHRITIC KNEE PAIN: A RANDOMIZED, CONTROLLED TRIAL
【24h】

COMPARISON OF THE EFFICACY AND SAFETY OF TRAMADOL VERSUS TAPENTADOL IN ACUTE OSTEOARTHRITIC KNEE PAIN: A RANDOMIZED, CONTROLLED TRIAL

机译:急性骨关节炎膝痛患者中曲马多与泰坦度的有效性和安全性比较:随机对照试验

获取原文

摘要

Objectives: Osteoarthritis of knee, a common disorder of elderly, has multifaceted pain mechanisms. Newer opioids such as tramadol and tapentadol target those multiple pain mechanisms, with few studies that compare them. We compared the efficacy and safety of tramadol versus tapentadol in acute episodes of osteoarthritic knee pain on 100 patients, 50 in each group. Methods: Group A received tramadol 50 mg twice daily for a period of 1-week, and Group B received tablet tapentadol 50 mg twice daily for a period of 1-week. Pain and function were evaluated by numerical pain rating scale (NPRS) and Western Ontario and McMaster Universities (WOMAC) questionnaire and scored during the initial baseline visit before the start of treatment. The efficacy of the drugs was evaluated at the end of 1 week follow-up by repeating the NPRS and WOMAC questionnaire. Adherence to medication was emphasized, and side effects of the drugs were evaluated by Naranjo’s scale. The data were analyzed statistically using descriptive statistics, namely, mean, standard deviation, and median. Non-parametric tests, namely, Mann–Whitney test, Wilcoxon signed rank test, and parametric tests such as unpaired t-test and paired t-test were used wherever applicable. All patients completed the study. Results: There was no statistically significant difference in the total WOMAC scoring between the two groups: Tramadol and tapentadol. However, tapentadol provided statistically significant pain relief compared to tramadol as measured by the NPRS. Both the groups tolerated the drugs well. There was no incidence of any adverse effects. Conclusion: Hence, both the drugs are efficacious in treating an acute painful episode of osteoarthritic knee pain and can be safely prescribed to the patients.
机译:目的:膝关节骨关节炎是老年人的常见疾病,具有多方面的疼痛机制。较新的阿片类药物(例如曲马多和他喷他多)针对的是多种疼痛机制,很少有研究将它们比较。我们比较了曲马多和他喷他多在100例患者(每组50例)的骨关节炎膝关节急性发作中的疗效和安全性。方法:A组每天两次两次接受曲马多50 mg,持续1周,B组每天两次两次接受50 mg的他喷他多片剂,持续1周。疼痛和功能通过数字疼痛评分量表(NPRS)以及西安大略和麦克马斯特大学(WOMAC)问卷进行评估,并在开始治疗前的最初基线访视时进行评分。在1周的随访结束时,通过重复NPRS和WOMAC调查表评估药物的疗效。强调对药物的依从性,并通过Naranjo量表评估药物的副作用。使用描述性统计量(即均值,标准差和中位数)对数据进行统计分析。在适用的情况下,使用非参数检验,即Mann-Whitney检验,Wilcoxon符号秩检验,以及非配对t检验和配对t检验等参数检验。所有患者均完成了研究。结果:曲马多和他喷他多两组在总WOMAC评分方面无统计学差异。然而,与NPRS相比,他喷他多与曲马多相比具有统计学上的显着止痛效果。两组均对药物耐受良好。没有任何不良反应的发生。结论:因此,这两种药物均能有效治疗骨关节炎膝关节疼痛的急性疼痛发作,并且可以安全地用于患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号